Peg L Aspatero 3750IU Injection

Peg L Aspatero 3750IU Injection Specification

Salt Composition
Asparaginase

Origin
India

Dosage Form
Injection

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Storage Instructions
Store at cool temperature

Peg L Aspatero 3750IU Injection Trade Information

Minimum Order Quantity
10 Pieces

Payment Terms
Cash in Advance (CID)

Supply Ability
40 Pieces Per Day

Delivery Time
2 Days

Sample Policy
Contact us for information regarding our sample policy

Main Domestic Market
All India

About Peg L Aspatero 3750IU Injection

Peg L Aspatero 3750IU Injection contains Asparaginase. It is mainly used to treat lymphoblastic lymphoma and acute lymphoblastic leukemia (ALL).

Tell your doctor if you are pregnant, planning to get pregnant, or nursing a baby because this medication may impair your immune system, raise your risk of infection, and necessitate effective contraception.

Brand Name: Peg L Aspatero

Composition: Asparaginase

Mechanism of Action:

Asparagine is hydrolyzed by pegaspargase to produce ammonia and aspartic acid. For cancer cells, asparagine is a necessary amino acid, particularly in some types of cancer like ALL. Pegaspargase efficiently starves the cancer cells, preventing their development and multiplication by lowering the blood levels of asparagine.

Uses:

Acute Lymphoblastic Leukemia
Lymphoblastic Lymphoma

Dosage and Administration:

Peg L. Aspatero is typically administered intravenously (IV) or intramuscularly (IM) at a dose of 3750 IU/m body surface area. Usually administered every 14 or 21 days, the dosage frequency varies depending on the particular treatment plan.

Side Effects: